Air Optix Plus HydraGlyde Multifocal Daily/Extended Wear Contact Lenses
NCT ID: NCT05886894
Last Updated: 2025-08-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
351 participants
OBSERVATIONAL
2023-08-08
2025-06-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Air Optix Daily Wear Contact Lenses
NCT05827224
Air Optix Extended Wear Contact Lenses
NCT05886881
Air Optix® Night and Day® Aqua Daily Wear
NCT05976750
Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Multifocal Contact Lenses
NCT05338333
Assessing the Clinical Performance of Two Frequent Replacement Silicone Hydrogel Multifocal Contact Lenses
NCT05702541
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Air Optix plus HydraGlyde Multifocal Daily Wear
Lotrafilcon B multifocal soft contact lenses with comfort additive worn in both eyes and removed daily for cleaning and disinfection
Lotrafilcon B multifocal soft contact lenses
Commercially available soft (hydrophilic) contact lenses indicated for the correction of presbyopia, with or without myopia or hyperopia
Air Optix plus HydraGlyde Multifocal Extended Wear
Lotrafilcon B multifocal soft contact lenses with comfort additive worn in both eyes worn on an extended wear basis. Extended wear is defined as up to 6 days continuous wear (including while sleeping/overnight).
Lotrafilcon B multifocal soft contact lenses
Commercially available soft (hydrophilic) contact lenses indicated for the correction of presbyopia, with or without myopia or hyperopia
Biofinity Multifocal Daily Wear
Comfilcon A multifocal soft contact lenses worn in both eyes and removed daily for cleaning and disinfection
Comfilcon A multifocal soft contact lenses
Commercially available soft (hydrophilic) contact lenses indicated for the correction of refractive ametropia (myopia and hyperopia) and emmetropia with presbyopia
Biofinity Multifocal Extended Wear
Comfilcon A multifocal soft contact lenses worn in both eyes worn on an extended wear basis. Extended wear is defined as up to 6 days continuous wear (including while sleeping/overnight).
Comfilcon A multifocal soft contact lenses
Commercially available soft (hydrophilic) contact lenses indicated for the correction of refractive ametropia (myopia and hyperopia) and emmetropia with presbyopia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lotrafilcon B multifocal soft contact lenses
Commercially available soft (hydrophilic) contact lenses indicated for the correction of presbyopia, with or without myopia or hyperopia
Comfilcon A multifocal soft contact lenses
Commercially available soft (hydrophilic) contact lenses indicated for the correction of refractive ametropia (myopia and hyperopia) and emmetropia with presbyopia
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must have worn or be wearing Air Optix plus Hydraglyde Multifocal or Biofinity Multifocal for at least 1 year in a daily wear modality, or 3 years in an extended wear modality;
Exclusion Criteria
* Use of systemic or ocular medications contraindicating regular contact lens wear at baseline and/or during the period of the retrospective chart collection;
* Slit lamp findings, including signs of pathological dry eye, that would contraindicate regular contact lens wear;
* Participation of the patient in a contact lens or contact lens care product trial during the period of the retrospective chart collection;
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Trial Lead, Vision Care
Role: STUDY_DIRECTOR
Alcon Research, LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Complete Family Vision Care
San Diego, California, United States
Pearle Vision
Jacksonville, Florida, United States
Jackson Health Community Center
Miami, Florida, United States
Vision Health Institute
Orlando, Florida, United States
Complete Eye Care of Medina
Medina, Minnesota, United States
Koetting Associates
St Louis, Missouri, United States
Sacco Eye Group
Vestal, New York, United States
Smith Bowman Ophthalmology
Salt Lake City, Utah, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CLJ241-N003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.